Clinical Trials Browser

Phase 2/3 × Breast Neoplasms × Zoledronic Acid × Clear all

NCT00524849 2010-09-14

Zometa and Circulating Vascular Endothelial Growth Factor (VEGF) in Breast Cancer Patients With Bone Metastasis

Phase 2/3 Completed

Breast Neoplasms